Heparin stimulates elastogenesis: Application to silk-based vascular grafts

Matrix Biology

Volumn 30, Issue 5-6, 2011, Pages 346-355

  Saitow, Cassandra ^a   Kaplan, David L ^a,b   Castellot, John J ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tufts University   (United States)

Author keywords

Elastin; Heparin; Silk; Vascular tissue engineering

Indexed keywords

ELASTIN; HEPARIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; BLOOD VESSEL GRAFT; CELL DENSITY; CELL GROWTH; CORONARY ARTERY BYPASS GRAFT; DEVELOPMENT; ELASTIC FIBER; ELASTIN SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RESTENOSIS; SILK; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; VASCULAR SMOOTH MUSCLE;

AGED; BIOCOMPATIBLE MATERIALS; CELL COUNT; CELL LINE, TRANSFORMED; CELL PROLIFERATION; ELASTIC TISSUE; ELASTIN; ENDOTHELIUM, VASCULAR; FEMALE; HEPARIN; HUMANS; MICROSCOPY, FLUORESCENCE; MYOCYTES, SMOOTH MUSCLE; PRIMARY CELL CULTURE; RNA, MESSENGER; SILK; STAINING AND LABELING; VASCULAR GRAFTING;

EID: 79960555928     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2011.04.005     Document Type: Article

References (35)

1. AHA Cardiovascular Procedures. Factsheet 2007.
2. Altman GH D.F., Jakuba C., Calabro T., Horan R.L., Chen J., Lu H., Richmond J., Kaplan D.L. Silk-based biomaterials. Biomaterials 2003, 24:401-416.
3. Arribas S.M., Briones A.M., Bellingham C., Gonzalez M.C., Salaices M., Liu K., Wang Y., Hinek A. Heightened aberrant deposition of hard-wearing elastin in conduit arteries of prehypertensive SHR is associated with increased stiffness and inward remodeling. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2299-H2307.
4. Cain S.A., Baldock C., Gallagher J., Morgan A., Bax D.V., Weiss A.S., Shuttleworth C.A., Kielty C.M. Fibrillin-1 interactions with heparin. Implications for microfibril and elastic fiber assembly. J. Biol. Chem. 2005, 280:30526-30537.
5. Castellot JJ A.M., Rosenberg R., Karnovsky M.J. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J. Cell Biol. 1981, 90:372-379.
6. Castellot J.J., Beeler D.L., Rosenberg R.D., Karnovsky M.J. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. J. Cell. Physiol. 1984, 120:315-320.
7. Coquerel B., Poyer F., Torossian F., Dulong V., Bellon G., Dubus I., Reber A., Vannier J.P. Elastin-derived peptides: matrikines critical for glioblastoma cell aggressiveness in a 3-D system. Glia 2009, 57:1716-1726.
8. Davis E.C. Stability of elastin in the developing mouse aorta: a quantitative radioautographic study. Histochemistry 1993, 100:17-26.
9. El-Hallous E., Sasaki T., Hubmacher D., Getie M., Tiedemann K., Brinckmann J., Batge B., Davis E.C., Reinhardt D.P. Fibrillin-1 interactions with fibulins depend on the first hybrid domain and provide an adaptor function to tropoelastin. J. Biol. Chem. 2007, 282:8935-8946.
10. Harris J.R., Seikaly H. Evaluation of polytetrafluoroethylene micrografts in microvascular surgery. J. Otolaryngol. 2002, 31:89-92.
11. Herman I.M., C.J.J. Regulation of vascular smooth muscle cell growth by endothelial-synthesized extracellular matrix. Arteriosclerosis 1987, 7:463-469.
12. Karnik S.K., Brooke B.S., Bayes-Genis A., Sorensen L., Wythe J.D., Schwartz R.S., Keating M.T., Li D.Y. A critical role for elastin signaling in vascular morphogenesis and disease. Development 2003, 130:411-423.
13. Katsuta Y., Ogura Y., Iriyama S., Goetinck P.F., Klement J.F., Uitto J., Amano S. Fibulin-5 accelerates elastic fibre assembly in human skin fibroblasts. Exp. Dermatol. 2008, 17:837-842.
14. Kelleher C.M., McLean S.E., Mecham R.P. Vascular extracellular matrix and aortic development. Curr. Top. Dev. Biol. 2004, 62:153-188.
15. Kielty C.M. Elastic fibres in health and disease. Expert Rev. Mol. Med. 2006, 8:1-23.
16. Kothapalli C.R., Ramamurthi A. Biomimetic regeneration of elastin matrices using hyaluronan and copper ion cues. Tissue Eng. A 2009, 15:103-113.
17. Kothapalli C.R., Ramamurthi A. Lysyl oxidase enhances elastin synthesis and matrix formation by vascular smooth muscle cells. J. Tissue Eng. Regen. Med. 2009, 3:655-661.
18. Lawrence B.D., Marchant J.K., Pindrus M.A., Omenetto F.G., Kaplan D.L. Silk film biomaterials for cornea tissue engineering. Biomaterials 2009, 30:1299-1308.
19. Lever R., Page C.P. Novel drug development opportunities for heparin. Nat. Rev. Drug Discov. 2002, 1:140-148.
20. Li C., Vepari C., Jin H.J., Kim H.J., Kaplan D.L. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 2006, 27:3115-3124.
21. Lovett M., Cannizzaro C., Daheron L., Messmer B., Vunjak-Novakovic G., Kaplan D.L. Silk fibroin microtubes for blood vessel engineering. Biomaterials 2007, 35:5271-5279.
22. Lovett M.L., Cannizzaro C.M., Vunjak-Novakovic G., Kaplan D.L. Gel spinning of silk tubes for tissue engineering. Biomaterials 2008, 29:4650-4657.
23. Maciag T., Mehlman T., Friesel R., Schreiber A.B. Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science 1984, 225:932-935.
24. McGowan S.E., Liu R., Harvey C.S. Effects of heparin and other glycosaminoglycans on elastin production by cultured neonatal rat lung fibroblasts. Arch. Biochem. Biophys. 1993, 302:322-331.
25. Mecham R.P., Lange G., Madaras J., Starcher B. Elastin synthesis by ligamentum nuchae fibroblasts: effects of culture conditions and extracellular matrix on elastin production. J. Cell Biol. 1981, 90:332-338.
26. Mishra-Gorur K., Castellot J.J. Heparin rapidly and selectively regulates tyrosine phosphorylation in vascular smooth muscle cells. J. Cell Physiol. 1999, 178:205-215.
27. Mitchell S.L., Niklason L.E. Requirements for growing tissue-engineered vascular grafts. Cardiovasc. Pathol. 2003, 12:59-64.
28. Owens G., Kumar M., Wamhoff B. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
29. Stearns N., Prigent-Richard S., Letourneur D., Castellot J.J. Synthesis and characterization of highly sensitive heparin probes for detection of heparin binding proteins. Analytical Biochemistry 1997, 247:348-356.
30. Swee M.H., Parks W.C., Pierce R.A. Developmental regulation of elastin production. Expression of tropoelastin pre-mRNA persists after down-regulation of steady-state mRNA levels. J. Biol. Chem. 1995, 270:14899-14906.
31. Tu Y., Weiss A.S. Glycosaminoglycan-mediated coacervation of tropoelastin abolishes the critical concentration, accelerates coacervate formation, and facilitates spherule fusion: implications for tropoelastin microassembly. Biomacromolecules 2008, 9:1739-1744.
32. Tu Y., Weiss A.S. Transient tropoelastin nanoparticles are early-stage intermediates in the coacervation of human tropoelastin whose aggregation is facilitated by heparan sulfate and heparin decasaccharides. Matrix Biol. 2010, 29:152-159.
33. Wachi H., Seyama Y., Tajima S. Modulation of elastin expression by heparin is dependent on the growth condition of vascular smooth muscle cells: up-regulation of elastin expression by heparin in the proliferating cells is mediated by the inhibition of protein kinase C activity. J. Biochem. 1995, 118:582-586.
34. Wang X., Zhang X., Castellot J., Herman I., Iafrati M., Kaplan D.L. Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses. Biomaterials 2008, 29(7):894-903.
35. Wu W.J., Vrhovski B., Weiss A.S. Glycosaminoglycans mediate the coacervation of human tropoelastin through dominant charge interactions involving lysine side chains. J. Biol. Chem. 1999, 274:21719-21724.